Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol, dexamethasone, and ondansetron for prevention of nausea and vomiting after cesarean section
IRCT20170408033280N3Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ondansetron, dexamethasone and propofol in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Nausea and vomiting after cesarean section. Started Jul 2019; status: completed.
02
Drugs
ondansetrondexamethasonepropofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20170408033280N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170408033280N3.